カテゴリ： MarketLine, アメリカ, 企業調査

The Chemours Company LLC：企業の戦略・SWOT・財務情報

◆英語タイトル：The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3720
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：41
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

The Chemours Company LLC – Strategy, SWOT and Corporate Finance Report
Summary

The Chemours Company LLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Chemours Company, LLC (Chemours) is a provider of performance chemicals. Its major products include titanium dioxide (TiO2), industrial fluoropolymer resins, sodium cyanide, refrigerants, and performance chemicals and intermediates. The company delivers customized solutions with a wide range of industrial and specialty chemicals products, and application expertise. It sells products under brands such as Ti-Pure, Opteon, Krytox, Teflon, Viton, Freon, and Nafion. The company serves plastics and coatings, mining, oil refining, refrigeration and air conditioning, electronics and general industries across North America, Asia Pacific, Europe, Middle East, Africa, and Latin America. Chemours is headquartered in Wilmington, Delaware, the US.

Scope

- Detailed information on The Chemours Company LLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Chemours Company LLC in the form of a SWOT analysis
- An in-depth view of the business model of The Chemours Company LLC including a breakdown and examination of key business segments
- Intelligence on The Chemours Company LLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Chemours Company LLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Chemours Company LLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Chemours Company LLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Chemours Company LLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
The Chemours Company LLC: Company Overview 9
The Chemours Company LLC: Overview and Key Facts 9
The Chemours Company LLC: Overview 9
The Chemours Company LLC: Key Facts 9
The Chemours Company LLC: Key Employees 11
The Chemours Company LLC: Key Employee Biographies 12
The Chemours Company LLC: Major Products and Services 14
The Chemours Company LLC: Company History 15
The Chemours Company LLC: Management Statement 16
The Chemours Company LLC: Locations and Subsidiaries 18
The Chemours Company LLC: Key Competitors 20
The Chemours Company LLC: Company Analysis 21
The Chemours Company LLC: Business Description 21
The Chemours Company LLC: SWOT Analysis 22
The Chemours Company LLC: SWOT Overview 22
The Chemours Company LLC: Strengths 22
The Chemours Company LLC: Weaknesses 23
The Chemours Company LLC: Opportunities 23
The Chemours Company LLC: Threats 24
The Chemours Company LLC: Corporate Financial Deals Activity 25
The Chemours Company LLC: Financial Deals Overview 25
The Chemours Company LLC: Top Deals 2014 – 2018YTD* 27
The Chemours Company LLC: Advisors 28
The Chemours Company LLC: Top Legal Advisors 28
The Chemours Company LLC: Top Financial Advisors 28
The Chemours Company LLC: Capital Raising 30
The Chemours Company LLC: Divestments 31
The Chemours Company LLC: Recent Developments 32
The Chemours Company LLC: News and Events Summary 32
The Chemours Company LLC: Business Expansion 34
The Chemours Company LLC: Contracts 34
The Chemours Company LLC: Corporate Governance 35
The Chemours Company LLC: Financial Deals 36
The Chemours Company LLC: Financial Performance 36
The Chemours Company LLC: Strategy and Operations 37
Appendix 39
Contact Us 39
Methodology 39
About MarketLine 40

List of Tables
Table 1: The Chemours Company LLC: Key Facts
Table 2: The Chemours Company LLC: Key Employees
Table 3: The Chemours Company LLC: Locations and Subsidiaries
Table 4: The Chemours Company LLC: Key Competitors
Table 5: The Chemours Company LLC: Deal Activity by Deal Type - Volume (TTM*)
Table 6: The Chemours Company LLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: The Chemours Company LLC: Top Deals 2014 - 2018YTD*
Table 8: The Chemours Company LLC: Legal Advisor Ranking by Value (US$m)
Table 9: The Chemours Company LLC: Financial Advisor Ranking by Value (US$m)
Table 10: The Chemours Company LLC: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: The Chemours Company LLC: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: The Chemours Company LLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: The Chemours Company LLC: Divestments by Geography (2014 - YTD*2018)
Table 14: The Chemours Company LLC: News and Events Summary
Table 15: The Chemours Company LLC: Business Expansion
Table 16: The Chemours Company LLC: Contracts
Table 17: The Chemours Company LLC: Corporate Governance
Table 18: The Chemours Company LLC: Financial Deals
Table 19: The Chemours Company LLC: Financial Performance
Table 20: The Chemours Company LLC: Strategy and Operations

List of Figures
Figure 1: The Chemours Company LLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Chemours Company LLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: The Chemours Company LLC: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: The Chemours Company LLC: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: The Chemours Company LLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: The Chemours Company LLC: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[The Chemours Company LLC：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Cerevance Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Cerevance Inc (Cerevance) is a pharmaceutical company that strives to develop medicines for the treatment of neurological and psychiatric diseases. It is also developing preclinical and clinical programs for Parkinson's disease, L-Dopa induced dyskinesia, cognitive impairment, neuroinflammat …
  • Omnicell Inc (OMCL)：企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Booz Allen Hamilton Holding Corporation (BAH)：企業の財務・戦略的SWOT分析
    Booz Allen Hamilton Holding Corporation (BAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Cook Medical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Cook Medical Inc (Cook Medical), that designs, develops and markets medical devices, biological materials and cellular therapies for healthcare market. The company offers products in the fields of critical care medicine, endoscopy, interventional radiology, urology, aortic intervention, lead …
  • Precision System Science Co Ltd (7707)-医療機器分野：企業M&A・提携分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company’s products include automated nucleic acid isolation system, large sample volume nucleic acid extraction sy …
  • AZTherapies Inc-製薬・医療分野：企業M&A・提携分析
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company, which focuses on the discovery, development and commercialization of medicines for the treatment of Alzheimer’s disease and other neuroinflammatory and neurodegenerative diseases. Its product pipeline includes the le …
  • Oracle Energy Corp (OEC)：石油・ガス：M&Aディール及び事業提携情報
    Summary Oracle Energy Corp (Oracle Energy) is an oil and gas company that operates development and redevelopment oil and natural gas projects. The company offers critical assessment and mitigation of risk in oil and gas exploration. It owns and operates oil and gas projects in Portugal's southern Lu …
  • New Jersey Resources Corp (NJR)：石油・ガス：M&Aディール及び事業提携情報
    Summary New Jersey Resources Corp (NJR) is a provider of natural gas delivery and energy services. The company offers services such as energy services, home services, energy management services and storage facilities. Its home services include home heating services, home AC services, electrical serv …
  • Christian Dior SE：企業の戦略・SWOT・財務情報
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Pharco Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Pharco Pharmaceuticals Inc (Pharco Pharmaceuticals), a subsidiary of Pharco Corp, is a manufacturer of branded and generic pharmaceutical products. The company offers products such as alambupine, alfatral, amlodipine, amrase, amrizole, bisadyl, bromhexine, carbolase, ciprofloxacin, dexametha …
  • Viatris Inc (VTRS)：企業の財務・戦略的SWOT分析
    Viatris Inc (VTRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • East-Central Iowa Rural Electric Cooperative：発電所・企業SWOT分析
    East-Central Iowa Rural Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • SSP Group Limited (Foodservice)：企業の戦略・SWOT・財務情報
    SSP Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary SSP Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BioStem Technologies Inc (BSEM)：製薬・医療：M&Aディール及び事業提携情報
    Summary BioStem Technologies Inc. (BioStem Technologies), formerly Caribbean International Holdings Inc., is a life sciences company that discovers, develops and manufactures pharmaceuticals and regenerative medicines. Through its subsidiaries, the company discovers, develops, produces and commercia …
  • Zynex Inc (ZYXI)：企業の財務・戦略的SWOT分析
    Summary Zynex Inc (Zynex) formerly Zynex Medical Inc operates as a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential curr …
  • Naspers Limited (NPN)：企業の財務・戦略的SWOT分析
    Naspers Limited (NPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wacker Neuson Se
    Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report Summary Wacker Neuson Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bel Fuse, Inc.：企業の戦略・SWOT・財務分析
    Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CeraPedics Inc-医療機器分野：企業M&A・提携分析
    Summary CeraPedics Inc (Cerapedics) is a provider of osteobiologic treatment solutions. The company’s products include i-factor putty and i-factor flex. Its i-factor putty is a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to …
  • Innovative Targeting Solutions Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Innovative Targeting Solutions Inc (ITS) is an antibody generation company that discovers and develops novel human monoclonal antibody technologies. The company develops a next generation protein engineering platform that helps for the generation of fully human antibody and T cell receptor b …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆